Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma.
Grisendi G, Dall'Ora M, Casari G, Spattini G, Farshchian M, Melandri A, Masicale V, Lepore F, Banchelli F, Costantini RC, D'Esposito A, Chiavelli C, Spano C, Spallanzani A, Petrachi T, Veronesi E, Ferracin M, Roncarati R, Vinet J, Magistri P, Catellani B, Candini O, Marra C, Eccher A, Bonetti LR, Horwtiz EM, Di Benedetto F, Dominici M. Grisendi G, et al. Among authors: ferracin m. Cell Rep Med. 2024 Aug 20;5(8):101685. doi: 10.1016/j.xcrm.2024.101685. Cell Rep Med. 2024. PMID: 39168103 Free PMC article.
ARID1A in cancer: Friend or foe?
Fontana B, Gallerani G, Salamon I, Pace I, Roncarati R, Ferracin M. Fontana B, et al. Among authors: ferracin m. Front Oncol. 2023 Feb 20;13:1136248. doi: 10.3389/fonc.2023.1136248. eCollection 2023. Front Oncol. 2023. PMID: 36890819 Free PMC article. Review.
Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study.
Diotallevi F, Matacchione G, Campanati A, Marinelli Busilacchi E, Viola N, Pace I, Fontana B, Roncarati R, Bonafè M, Ferracin M, Sabbatinelli J, Olivieri F. Diotallevi F, et al. Among authors: ferracin m. Dermatol Ther (Heidelb). 2025 Jan 12. doi: 10.1007/s13555-024-01331-9. Online ahead of print. Dermatol Ther (Heidelb). 2025. PMID: 39800831
Synergic activity of FGFR2 and MEK inhibitors in the treatment of FGFR2-amplified cancers of unknown primary.
Cavazzoni A, Salamon I, Fumarola C, Gallerani G, Laprovitera N, Gelsomino F, Riefolo M, Rihawi K, Porcellini E, Rossi T, Mazzeschi M, Naddeo M, Serravalle S, Broseghini E, Agostinis F, Deas O, Roncarati R, Durante G, Pace I, Lauriola M, Garajova I, Calin GA, Bonafè M, D'Errico A, Petronini PG, Cairo S, Ardizzoni A, Sales G, Ferracin M. Cavazzoni A, et al. Among authors: ferracin m. Mol Ther. 2024 Oct 2;32(10):3650-3668. doi: 10.1016/j.ymthe.2024.07.011. Epub 2024 Jul 20. Mol Ther. 2024. PMID: 39033323 Free PMC article.
Defining high-risk patients: beyond the 8the AJCC melanoma staging system.
Broseghini E, Veronesi G, Gardini A, Venturi F, Scotti B, Vespi L, Marchese PV, Melotti B, Comito F, Corti B, Ferracin M, Dika E. Broseghini E, et al. Among authors: ferracin m. Arch Dermatol Res. 2024 Dec 6;317(1):78. doi: 10.1007/s00403-024-03627-4. Arch Dermatol Res. 2024. PMID: 39643819
Epigenetic age acceleration in hematopoietic stem cell transplantation.
Ursi M, Kwiatkowska KM, Pirazzini C, Storci G, Messelodi D, Bertuccio SN, De Matteis S, Iannotta F, Tomassini E, Roberto M, Naddeo M, Laprovitera N, Salamon I, Sinigaglia B, Dan E, De Felice F, Barbato F, Maffini E, Falcioni S, Arpinati M, Ferracin M, Bonafè M, Garagnani P, Bonifazi F. Ursi M, et al. Among authors: ferracin m. Haematologica. 2024 Oct 3. doi: 10.3324/haematol.2024.285291. Online ahead of print. Haematologica. 2024. PMID: 39363850 Free article.
Pre-transplant CD69+ extracellular vesicles are negatively correlated with active ATLG serum levels and associate with the onset of GVHD in allogeneic HSCT patients.
Storci G, Barbato F, Ricci F, Tazzari PL, De Matteis S, Tomassini E, Dicataldo M, Laprovitera N, Arpinati M, Ursi M, Maffini E, Campanini E, Dan E, Manfroi S, Santi S, Ferracin M, Bonafe M, Bonifazi F. Storci G, et al. Among authors: ferracin m. Front Immunol. 2023 Jan 13;13:1058739. doi: 10.3389/fimmu.2022.1058739. eCollection 2022. Front Immunol. 2023. PMID: 36713433 Free PMC article.
Case report: Senescence as mechanism of resistance to Pembrolizumab in a Lymphoma patient who failed CD19-Targeted CAR-T cell therapy.
De Matteis S, Casadei B, Lolli G, Dicataldo M, Barbato F, Dan E, Paccagnella A, Sinigaglia B, Bertuzzi C, Arcari A, Zazzeroni L, Bernuzzi P, Laprovitera N, Storci G, Bertuccio SN, Ferracin M, Bonafè M, Zinzani PL, Bonifazi F. De Matteis S, et al. Among authors: ferracin m. Front Immunol. 2022 Oct 6;13:994731. doi: 10.3389/fimmu.2022.994731. eCollection 2022. Front Immunol. 2022. PMID: 36275688 Free PMC article.
Peripheral blood cellular profile at pre-lymphodepletion is associated with CD19-targeted CAR-T cell-associated neurotoxicity.
De Matteis S, Dicataldo M, Casadei B, Storci G, Laprovitera N, Arpinati M, Maffini E, Cortelli P, Guarino M, Vaglio F, Naddeo M, Sinigaglia B, Zazzeroni L, Guadagnuolo S, Tomassini E, Bertuccio SN, Messelodi D, Ferracin M, Bonafè M, Zinzani PL, Bonifazi F. De Matteis S, et al. Among authors: ferracin m. Front Immunol. 2023 Jan 16;13:1058126. doi: 10.3389/fimmu.2022.1058126. eCollection 2022. Front Immunol. 2023. PMID: 36726971 Free PMC article.
189 results